Kristine Peterson - 22 Apr 2024 Form 4 Insider Report for ArriVent Biopharma, Inc. (AVBP)

Role
Director
Signature
/s/ James Kastenmayer, Attorney-in-Fact for Kristine Peterson
Issuer symbol
AVBP
Transactions as of
22 Apr 2024
Net transactions value
$0
Form type
4
Filing time
23 Apr 2024, 16:06:26 UTC
Previous filing
23 Apr 2024
Next filing
28 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVBP Stock Option (right to buy) Award $0 +28,587 $0.000000 28,587 22 Apr 2024 Common Stock 28,587 $15.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest on the first anniversary of the grant date, subject to the Reporting Person's continued service through the applicable vesting date.